Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. Pylori infection in duodenal ulcer patients

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 2, 1996, Pages 211-213

  Parente, F ^a   Maconi, G ^a   Bargiggia, S ^a   Colombo, E ^b   Bianchi Porro, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Garbagnate Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; LANSOPRAZOLE; TINIDAZOLE;

ABDOMINAL PAIN; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH;

EID: 0029870040     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.729121000.x     Document Type: Article

References (12)

1. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of the Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
2. Lanbenz J, Leverkus F, Borsch G. Omeprazole plus amoxycillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994; 29: 1070-5.
3. Bayerdorffer E, Miehlke S, Mannes G, et al. Double-blind trial of omeprazole and amoxycillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108: 1412-7.
4. Labenz J, Gyenes E, Ruhl GH. Borsch G. Omeprazole plus amoxycillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491-5.
5. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29 (Suppl. 201): 16-23.
6. Lazzaroni M, Maconi G, Bargiggia S, et al. Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence. Eur J Gastroenterol Hepatol 1995; 7: 117-9.
7. Goddard A, Logan R. One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1-3.
8. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35: 490-6.
9. De Korwin JD, Joubert M, Bazin N, et al. Lansoprazole plus antibiotics in the treatment of peptic ulcer disease. Gastroenterology 1993; 104 (Suppl.): A67. (Abstract.)
10. Burette A, Glupczynski Y, Perez V, et al. Lansoprazole plus roxithromycin and metronidazole for eradication of H. pylori: results of a single-blind pilot study. Acta Gastroenterol Belg 1993; 101 (Suppl. 131). (Abstract.)
11. Vakie N, Bauer D, Pentz T. Eradication rate of Helicobacter pylori with dual therapy with lansoprazole and clarithromycin in an office based study. Am J Gastroenterol 1995; 30: 1667 (Abstract).
12. de Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-20.